Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial.

J Grotta; W Clark; B Coull; L C Pettigrew; B Mackay; L B Goldstein; I Meissner; D Murphy; L LaRue

doi:10.1161/01.str.26.4.602

Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial.

Identifier:nobleid.org/w1/20260515/DB2ABE51

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DB2ABE51.svg?ark=w1%2F20260515%2FDB2ABE51)](https://nobleid.org/work/w1/20260515/DB2ABE51)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial.

Identifier:nobleid.org/w1/20260515/DB2ABE51

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DB2ABE51.svg?ark=w1%2F20260515%2FDB2ABE51)](https://nobleid.org/work/w1/20260515/DB2ABE51)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work